Skip to content

Absci Corp Sustainability Reports

Absci Corporation is a clinical-stage biotechnology company that utilizes data-first generative artificial intelligence (AI) combined with scalable wet lab technologies to predict, design, and create optimized biologic drug candidates and therapeutics.

Sector: Professional & technical services

Country: United States

Exchange: Nasdaq

FIGI: BBG011N54DC3

3 reports from 2021 to 2023